414 related articles for article (PubMed ID: 24029591)
1. Lymphangiogenesis and lymphatic function in periodontal disease.
Berggreen E; Wiig H
J Dent Res; 2013 Dec; 92(12):1074-80. PubMed ID: 24029591
[TBL] [Abstract][Full Text] [Related]
2. Lymphatic function and responses in periodontal disease.
Berggreen E; Wiig H
Exp Cell Res; 2014 Jul; 325(2):130-7. PubMed ID: 24503053
[TBL] [Abstract][Full Text] [Related]
3. Lymphangiogenesis is induced during development of periodontal disease.
Mkonyi LE; Bakken V; Søvik JB; Mauland EK; Fristad I; Barczyk MM; Bletsa A; Berggreen E
J Dent Res; 2012 Jan; 91(1):71-7. PubMed ID: 21979132
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins.
Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K
Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646
[TBL] [Abstract][Full Text] [Related]
5. Lymphangiogenesis Facilitates Initial Lymph Formation and Enhances the Dendritic Cell Mobilizing Chemokine CCL21 Without Affecting Migration.
Karlsen TV; Reikvam T; Tofteberg A; Nikpey E; Skogstrand T; Wagner M; Tenstad O; Wiig H
Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):2128-2135. PubMed ID: 28935759
[TBL] [Abstract][Full Text] [Related]
6. Molecular control of lymphatic metastasis.
Achen MG; Stacker SA
Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor D is dispensable for development of the lymphatic system.
Baldwin ME; Halford MM; Roufail S; Williams RA; Hibbs ML; Grail D; Kubo H; Stacker SA; Achen MG
Mol Cell Biol; 2005 Mar; 25(6):2441-9. PubMed ID: 15743836
[TBL] [Abstract][Full Text] [Related]
8. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
9. Role of lymphangiogenesis and lymphangiogenic factors during pancreatic cancer progression and lymphatic spread.
Schneider M; Büchler P; Giese N; Giese T; Wilting J; Büchler MW; Friess H
Int J Oncol; 2006 Apr; 28(4):883-90. PubMed ID: 16525637
[TBL] [Abstract][Full Text] [Related]
10. Role of Hyperplasia of Gingival Lymphatics in Periodontal Inflammation.
Papadakou P; Bletsa A; Yassin MA; Karlsen TV; Wiig H; Berggreen E
J Dent Res; 2017 Apr; 96(4):467-476. PubMed ID: 28081372
[TBL] [Abstract][Full Text] [Related]
11. New insights into the molecular control of the lymphatic vascular system and its role in disease.
Cueni LN; Detmar M
J Invest Dermatol; 2006 Oct; 126(10):2167-77. PubMed ID: 16983326
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.
Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA
Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020
[TBL] [Abstract][Full Text] [Related]
13. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation.
Saharinen P; Tammela T; Karkkainen MJ; Alitalo K
Trends Immunol; 2004 Jul; 25(7):387-95. PubMed ID: 15207507
[No Abstract] [Full Text] [Related]
14. Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues.
Lohela M; Heloterä H; Haiko P; Dumont DJ; Alitalo K
Am J Pathol; 2008 Dec; 173(6):1891-901. PubMed ID: 18988807
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of VEGF ligands and receptors in prostate cancer.
Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
[TBL] [Abstract][Full Text] [Related]
16. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
Nykänen AI; Sandelin H; Krebs R; Keränen MA; Tuuminen R; Kärpänen T; Wu Y; Pytowski B; Koskinen PK; Ylä-Herttuala S; Alitalo K; Lemström KB
Circulation; 2010 Mar; 121(12):1413-22. PubMed ID: 20231530
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of lymphangiogenesis.
Takahashi M; Yoshimoto T; Kubo H
Int J Hematol; 2004 Jul; 80(1):29-34. PubMed ID: 15293565
[TBL] [Abstract][Full Text] [Related]
18. VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane.
Oh SJ; Jeltsch MM; Birkenhäger R; McCarthy JE; Weich HA; Christ B; Alitalo K; Wilting J
Dev Biol; 1997 Aug; 188(1):96-109. PubMed ID: 9245515
[TBL] [Abstract][Full Text] [Related]
19. Lymphatic vessels assessment in feline mammary tumours.
Sarli G; Sassi F; Brunetti B; Rizzo A; Diracca L; Benazzi C
BMC Cancer; 2007 Jan; 7():7. PubMed ID: 17222331
[TBL] [Abstract][Full Text] [Related]
20. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
